Aprea Therapeutics, Inc. Increase (Decrease) in Deferred Income Taxes
Aprea Therapeutics, Inc. (APRE) reported Increase (Decrease) in Deferred Income Taxes of -$100.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2021-03-16
- Aprea Therapeutics, Inc. increase (decrease) in deferred income taxes for fiscal 2019 was -$100.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 1 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|
| 2019-12-31 | -$100.00K 10-K · filed 2020-03-27 | |
| 2018-06-30 | -$700.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |